FU
Fulcrum Ther
FULC·NASDAQCambridge MAFounded 201660 employees
Small CapbiotechPublicRare Disease
Platform: FTX-6058 SCD
Market Cap
$0.3B
All Drugs
2
Clinical Trials
4
Failed / Terminated
0
FDA Approved
0
Stock Price & Catalysts (FULC)
Loading FULC stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Fixaderotide | FUL-8065 | Phase 2/3 | 2 | B7-H3 | CKDFTD | ||
| Lisozasiran | FUL-8036 | NDA/BLA | 2 | IL-17A | ADPKDMyelofibrosis |
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (3)